138 related articles for article (PubMed ID: 36585434)
1. MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.
Tosoian JJ; Sessine MS; Trock BJ; Ross AE; Xie C; Zheng Y; Samora NL; Siddiqui J; Niknafs Y; Chopra Z; Tomlins S; Kunju LP; Palapattu GS; Morgan TM; Wei JT; Salami SS; Chinnaiyan AM
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):563-567. PubMed ID: 36585434
[TBL] [Abstract][Full Text] [Related]
2. Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.
Tosoian JJ; Trock BJ; Morgan TM; Salami SS; Tomlins SA; Spratt DE; Siddiqui J; Kunju LP; Botbyl R; Chopra Z; Pandian B; Eyrich NW; Longton G; Zheng Y; Palapattu GS; Wei JT; Niknafs YS; Chinnaiyan AM
J Urol; 2021 Mar; 205(3):732-739. PubMed ID: 33080150
[TBL] [Abstract][Full Text] [Related]
3. Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.
Tosoian JJ; Singhal U; Davenport MS; Wei JT; Montgomery JS; George AK; Salami SS; Mukundi SG; Siddiqui J; Kunju LP; Tooke BP; Ryder CY; Dugan SP; Chopra Z; Botbyl R; Feng Y; Sessine MS; Eyrich NW; Ross AE; Trock BJ; Tomlins SA; Palapattu GS; Chinnaiyan AM; Niknafs YS; Morgan TM
Urology; 2022 Jun; 164():184-190. PubMed ID: 34906585
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.
Tosoian JJ; Zhang Y; Xiao L; Xie C; Samora NL; Niknafs YS; Chopra Z; Siddiqui J; Zheng H; Herron G; Vaishampayan N; Robinson HS; Arivoli K; Trock BJ; Ross AE; Morgan TM; Palapattu GS; Salami SS; Kunju LP; Tomlins SA; Sokoll LJ; Chan DW; Srivastava S; Feng Z; Sanda MG; Zheng Y; Wei JT; Chinnaiyan AM;
JAMA Oncol; 2024 Apr; ():. PubMed ID: 38635241
[TBL] [Abstract][Full Text] [Related]
5. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
[TBL] [Abstract][Full Text] [Related]
6. Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.
Merdan S; Tomlins SA; Barnett CL; Morgan TM; Montie JE; Wei JT; Denton BT
Cancer; 2015 Nov; 121(22):4071-9. PubMed ID: 26280815
[TBL] [Abstract][Full Text] [Related]
7. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
[TBL] [Abstract][Full Text] [Related]
8. Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study.
Tosoian JJ; Dunn RL; Niknafs YS; Saha A; Vince RA; St Sauver JL; Jacobson DJ; McGree ME; Siddiqui J; Groskopf J; Jacobsen SJ; Tomlins SA; Kunju LP; Morgan TM; Salami SS; Wei JT; Chinnaiyan AM; Sarma AV
Eur Urol Open Sci; 2021 Jul; 29():30-35. PubMed ID: 34337531
[TBL] [Abstract][Full Text] [Related]
9. A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy.
McKiernan J; Noerholm M; Tadigotla V; Kumar S; Torkler P; Sant G; Alter J; Donovan MJ; Skog J
BMC Urol; 2020 Sep; 20(1):138. PubMed ID: 32873277
[TBL] [Abstract][Full Text] [Related]
10. Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer.
Sanda MG; Feng Z; Howard DH; Tomlins SA; Sokoll LJ; Chan DW; Regan MM; Groskopf J; Chipman J; Patil DH; Salami SS; Scherr DS; Kagan J; Srivastava S; Thompson IM; Siddiqui J; Fan J; Joon AY; Bantis LE; Rubin MA; Chinnayian AM; Wei JT; ; Bidair M; Kibel A; Lin DW; Lotan Y; Partin A; Taneja S
JAMA Oncol; 2017 Aug; 3(8):1085-1093. PubMed ID: 28520829
[TBL] [Abstract][Full Text] [Related]
11. Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.
Salami SS; Schmidt F; Laxman B; Regan MM; Rickman DS; Scherr D; Bueti G; Siddiqui J; Tomlins SA; Wei JT; Chinnaiyan AM; Rubin MA; Sanda MG
Urol Oncol; 2013 Jul; 31(5):566-71. PubMed ID: 21600800
[TBL] [Abstract][Full Text] [Related]
12. Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen.
Eyrich NW; Wei JT; Niknafs YS; Siddiqui J; Ellimoottil C; Salami SS; Palapattu GS; Mehra R; Kunju LP; Tomlins SA; Chinnaiyan AM; Morgan TM; Tosoian JJ
Urol Oncol; 2022 Jan; 40(1):4.e1-4.e7. PubMed ID: 34753659
[TBL] [Abstract][Full Text] [Related]
13. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.
Marks LS; Fradet Y; Deras IL; Blase A; Mathis J; Aubin SM; Cancio AT; Desaulniers M; Ellis WJ; Rittenhouse H; Groskopf J
Urology; 2007 Mar; 69(3):532-5. PubMed ID: 17382159
[TBL] [Abstract][Full Text] [Related]
14. Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
Wei JT; Feng Z; Partin AW; Brown E; Thompson I; Sokoll L; Chan DW; Lotan Y; Kibel AS; Busby JE; Bidair M; Lin DW; Taneja SS; Viterbo R; Joon AY; Dahlgren J; Kagan J; Srivastava S; Sanda MG
J Clin Oncol; 2014 Dec; 32(36):4066-72. PubMed ID: 25385735
[TBL] [Abstract][Full Text] [Related]
15. Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies.
De Luca S; Passera R; Cappia S; Bollito E; Randone DF; Milillo A; Papotti M; Porpiglia F
BJU Int; 2014 Dec; 114(6b):E56-E61. PubMed ID: 24472071
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy.
Ochiai A; Okihara K; Kamoi K; Oikawa T; Shimazui T; Murayama S; Tomita K; Umekawa T; Uemura H; Miki T
BJU Int; 2013 May; 111(6):928-33. PubMed ID: 23331404
[TBL] [Abstract][Full Text] [Related]
17. Economic Evaluation of Urine-Based or Magnetic Resonance Imaging Reflex Tests in Men With Intermediate Prostate-Specific Antigen Levels in the United States.
Jiao B; Gulati R; Hendrix N; Gore JL; Rais-Bahrami S; Morgan TM; Etzioni R
Value Health; 2021 Aug; 24(8):1111-1117. PubMed ID: 34372976
[TBL] [Abstract][Full Text] [Related]
18. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study.
Gittelman MC; Hertzman B; Bailen J; Williams T; Koziol I; Henderson RJ; Efros M; Bidair M; Ward JF
J Urol; 2013 Jul; 190(1):64-9. PubMed ID: 23416644
[TBL] [Abstract][Full Text] [Related]
19. Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.
Stephan C; Jung K; Semjonow A; Schulze-Forster K; Cammann H; Hu X; Meyer HA; Bögemann M; Miller K; Friedersdorff F
Clin Chem; 2013 Jan; 59(1):280-8. PubMed ID: 23213079
[TBL] [Abstract][Full Text] [Related]
20. The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy.
Stonier T; Simson N; Shah T; Lobo N; Amer T; Lee SM; Bass E; Chau E; Grey A; McCartan N; Acher P; Ahmad I; Arumainayagam N; Brown D; Chapman A; Elf D; Hartington T; Ibrahim I; Leung H; Liyanage S; Lovegrove C; Malthouse T; Mateen B; Mistry K; Morrison I; Nalagatla S; Persad R; Pope A; Sokhi H; Syed H; Tadtayev S; Tharmaratnam M; Qteishat A; Miah S; Emberton M; Moore C; Walton T; Eddy B; Ahmed HU
Eur Urol Focus; 2021 Sep; 7(5):1027-1034. PubMed ID: 33046412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]